Press release
Global HER-2 Targeted Drugs for Breast Cancer Market Projected to Grow at a CAGR of 5.5% from 2022 to 2030, Driven by Increasing Incidence and Technological Advancements
Dataintelo has recently published a report stating that the global market for HER-2 Targeted Drugs for Breast Cancer is slated to grow at a CAGR of 5.5% over the next decade (2022 to 2030). The growth attributes highlighted in the report include the escalating incidence of breast cancer, ongoing technological advancements in oncology, and a surge in awareness about HER-2-targeted drugs. By type, the market has been segmented into trastuzumab, pertuzumab, lapatinib, nera in 2tinib, trastuzumab emtansine (TACE), pyrogenic, and other types. Trastuzumab held the largest market share due to its documented efficacy and safety profiles. However, lapatinib is projected to be the fastest-growing segment. According to the report, drug applications are spread across hospital pharmacies, clinic pharmacies, drug stores, and other sectors.This study informs influential strategic decisions for relevant stakeholders. These include pharmaceutical companies, researcher and product developers, policymakers, and the medical community who can leverage this invaluable insight for planning and implementing effective business strategies. With the HER-2 targeted drug market continuing to expand, this report's findings underline a critical area of focus within oncology drug development and treatment options.
A plethora of factors is credited with the anticipated market growth. Firstly, global incidences of breast cancer continue to rise, pushing the medical fraternity to search for effective targeted treatments. Similarly, technological advances are enabling breakthroughs in areas that were untapped in oncology. Inherently, the awareness about the use of HER-2 drugs to target breast cancer is gaining momentum, fueling demand and appreciation for such drugs.
Segments such as trastuzumab and lapatinib demonstrate exciting potential in the forecast period. Trastuzumab, known for its enhanced safety and efficacy, leads the pack in terms of market share. Simultaneously, lapatinib is expected to exhibit rapid growth due to robust clinical data supporting its efficacy when combined with trastuzumab therapy.
The report's insight into various channels of drug applications emphasizes the importance of a comprehensive understanding of the market landscape. Recognizing the roles, hospital pharmacies, clinic pharmacies, drug stores, and other sectors play in drug application could be instrumental for the relevant stakeholders in planning strategies to tap into the market's immense potential
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐๐ซ๐๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ @ https://dataintelo.com/request-sample/61672
๐๐ก๐ข๐ฌ ๐ข๐ฌ ๐จ๐ง๐ ๐จ๐ ๐ญ๐ก๐ ๐ฆ๐จ๐ฌ๐ญ ๐๐๐ญ๐๐ข๐ฅ๐๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ง๐ ๐๐จ๐ฏ๐๐ซ ๐ญ๐ก๐ ๐๐จ๐ฅ๐ฅ๐จ๐ฐ๐ข๐ง๐ ๐ฌ๐๐ ๐ฆ๐๐ง๐ญ๐ฌ:
The her-2 targeted drugs for breast cancer market has been segmented on the basis of๐๐ฒ๐ฉ๐
โ Trastuzumab
โ Pertuzumab
โ Lapatinib
โ Neratinib
โ Trastuzumab Emtansine
โ Pyrotinib
โ Other
๐๐ฉ๐ฉ๐ฅ๐ข๐๐๐ญ๐ข๐จ๐ง
โ Hospital
โ Clinic
โ Drug Center
โ Other
๐๐ง๐-๐๐ฌ๐๐ซ
โ Adult
โ Pediatric
๐๐ข๐ฌ๐ญ๐ซ๐ข๐๐ฎ๐ญ๐ข๐จ๐ง ๐๐ก๐๐ง๐ง๐๐ฅ
โ Hospital Pharmacy
โ Retail Pharmacy
โ Online Pharmacy
๐๐๐ ๐ข๐จ๐ง
โ Asia Pacific
โ North America
โ Latin America
โ Europe
โ Middle East & Africa
๐๐๐ฒ ๐๐ฅ๐๐ฒ๐๐ซ๐ฌ
โ Roche
โ Chugai Pharmaceutical
โ GlaxoSmithKline
โ Novartis
โ Pfizer
โ CANbridge
โ Puma Biotechnology
โ Hengrui Medicine
โ Beacon Pharmaceuticals Limited
โ Hetero Drugs
The HER-2 Targeted Drugs for Breast Cancer market is segmented by the type of drug, its application, the end-user, and distribution channel. Different drugs such as Trastuzumab, Pertuzumab, Lapatinib, Neratinib, Trastuzumab Emtansine, Pyrotinib, and others are used as HER-2 targeted drugs for breast cancer treatment. These drugs are used in various settings such as hospitals, clinics, and drug centers, therefore; the market has been categorized based on its applications. In terms of the end-user demographic, the market is divided into Adults and Pediatrics. Further, distribution channels like Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy play a crucial role in the dissemination of these targeted drugs.
Region wise, the HER-2 Targeted drugs for breast cancer market is analyzed for Asia Pacific, North America, Latin America, Europe, Middle East, and Africa. North America, with a high incidence of breast cancer, has a substantial market share, whereas Asia Pacific is expected to exhibit substantial growth in the HER-2 targeted drugs market due to increased healthcare awareness and advancements in healthcare infrastructure. Europe and Latin America also contribute considerably to the overall market growth. The key players that have been studied in this market include Roche, Chugai Pharmaceutical, GlaxoSmithKline, Novartis, Pfizer, CANbridge, Puma Biotechnology, Hengrui Medicine, Beacon Pharmaceuticals Limited, and Hetero Drugs
๐๐๐ช๐ฎ๐๐ฌ๐ญ ๐ ๐๐ซ๐๐ ๐ฌ๐๐ฆ๐ฉ๐ฅ๐ ๐ซ๐๐ฉ๐จ๐ซ๐ญ @ https://dataintelo.com/request-sample/61672
Market Drivers:
1. Increased prevalence of breast cancer: The rising number of breast cancer patients around the world is a major market driver. As per the World Health Organization (WHO), breast cancer is the most prevalent type of cancer among women globally.
2. Advancements in healthcare: The development and success of targeted therapies for breast cancer therapy have driven the demand for HER-2 targeted drugs.
3. Raised awareness about early diagnosis: A heightened awareness about the importance of early diagnosis of breast cancer could significantly impact the growth of the market.
4. Improved healthcare infrastructure: The improvement in healthcare facilities, especially in emerging economies, has also played a significant role in the growth of this market.
Opportunities:
1. Expansion in developing regions: There are vast opportunities for the HER-2 targeted drugs for breast cancer market in the developing regions such as Asia-Pacific and Africa due to the surging healthcare sector.
2. Research and development opportunities: There are numerous opportunities for the manufacturers in the market to invest in research and development activities for the development of more efficient drugs.
3. Personalized medicine: Advances in personalized medicine and genomics offer opportunities for the development of new HER-2 targeted drugs, which can specifically target the genetic mutations causing the cancer.
4. Combination therapies: The opportunity to develop and market combination therapies, which use multiple drugs used together to enhance the beneficial effects and lower resistance could be a significant opportunity.
5. Educational campaigns: Companies can seize opportunities through educational campaigns that encourage early screening for breast cancer and create a higher demand for the drug
๐๐จ๐ฎ ๐๐๐ง ๐๐ข๐ซ๐๐๐ญ๐ฅ๐ฒ ๐๐ฎ๐ฒ ๐ญ๐ก๐ข๐ฌ ๐ซ๐๐ฉ๐จ๐ซ๐ญ ๐๐ซ๐จ๐ฆ: https://dataintelo.com/checkout/61672
This report would be valuable to business executives, managers, and other decision makers in industries, like healthcare, finance, technology, and more, who need insights on market trends, consumer behavior, competitive analysis, future predictions, and other crucial data-driven information for strategic planning and business growth.
Dataintelo is a reliable and leading provider of market research reports across all sectors. They utilize advanced data intelligence methods while also assuring high accuracy and thoroughness in their reports. Their information helps to guide the strategy and decision making of businesses all over the world. Dataintelo boasts an experienced team of analysts who constantly monitor markets in various industries. The advantages of using Dataintelo include:
1. Comprehensive Reports: Their reports are comprehensive, covering all necessary aspects of market analysis such as industry outlook, market segmentation, competition scenario, and consumer behavior.
2. Accuracy and Precision: Dataintelo ensures data accuracy and precision by utilizing advanced analytical tools and methodologies.
3. Business Growth: With detailed insights about current market trends, future prospects, and competitive landscape, businesses can make informed decisions that contribute to their growth and profitability.
4. Customization: They offer custom research services to cater to individual client requirements, ensuring the most relevant and beneficial insights for their specific business.
5. Excellent Customer Service: Dataintelo's customer service team is very responsive and caters to all queries in a quick and efficient manner. They offer 24/7 customer support to help you at any step of your research journey.
6. Affordable: Compared to the wealth of information you get, their reports are reasonably priced, offering substantial value for money.
7. Quality: Their reports are compiled by industry experts and verified by market professionals, which ensure high-quality and trustworthy insights
Contact Us :
Dataintelo
Name - Alex Mathews
Phone No.: +1 909 414 1393
Email - sales@dataintelo.com
Website - https://dataintelo.com
Address - 500 East E Street, Ontario, CA 91764, United States.
๐๐๐ฉ๐จ๐ซ๐ญ ๐๐๐ง ๐๐ ๐๐ฎ๐ฌ๐ญ๐จ๐ฆ๐ข๐ณ๐๐ ๐๐ฌ ๐ฉ๐๐ซ ๐ฒ๐จ๐ฎ๐ซ ๐ง๐๐๐.
๐๐ฆ๐๐ข๐ฅ ๐ฎ๐ฌ ๐จ๐ง - ๐ฌ๐๐ฅ๐๐ฌ@๐๐๐ญ๐๐ข๐ง๐ญ๐๐ฅ๐จ.๐๐จ๐ฆ
๐๐๐จ๐ฎ๐ญ ๐๐๐ญ๐๐ข๐ง๐ญ๐๐ฅ๐จ:
๐๐๐ญ๐๐ข๐ง๐ญ๐๐ฅ๐จ boasts extensive experience in creating tailored Market research reports across diverse industry verticals. With in-depth Market analysis, creative business strategies for new entrants, and insights into the current Market scenario, our reports undergo intensive primary and secondary research, interviews, and consumer surveys.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global HER-2 Targeted Drugs for Breast Cancer Market Projected to Grow at a CAGR of 5.5% from 2022 to 2030, Driven by Increasing Incidence and Technological Advancements here
News-ID: 3525279 • Views: โฆ
More Releases from Dataintelo

Carbon Carbon Composite Brake Disc Market Projected to Grow at a Steady CAGR of โฆ
Dataintelo has recently unveiled a comprehensive analysis on the Carbon Carbon Composite Brake Disc Market in its latest report. The research, which is segmented by Type (2D C/C composite, 2.5D C/C composite, 3D C/C composite), by Manufacturing Process (Blow Moulding, Injection Moulding) and by Application (Motorsport, Aerospace, Heavy Vehicles), among other factors, anticipates the market to grow at a significant CAGR of XX% during the forecast period.
The report considersโฆ

AR Optical Waveguide Module Market to Expand at a Significant CAGR, Revealed in โฆ
Dataintelo has recently published a comprehensive study on the AR Optical Waveguide Module Market, revealing a forecast annual growth rate (CAGR) of XX%. The report is detailed and breaks down its research by aspects such as Light Detection (Infrared, Ultraviolet, Visible Light), Waveguide Type (Planar Waveguide, Channel Waveguide), Material Type (Polymer, LiNbO3, Glass, Silicon), Application (Telecommunication, Healthcare, Industrial, Aerospace and Defense), and Component (Input/Output Coupler, Waveguide Core, Cladding).
The report segmentsโฆ

6-Axis Robots Market Expected to Witness Significant Growth, Focusing on Key Pla โฆ
In a newly published report from Dataintelo, it is revealed that the 6-Axis Robots Market is projected to experience a substantial growth, marking a significant CAGR in the forecast period. The comprehensive study is segmented by type, including Articulated, Cylindrical, Spherical, and Cartesian robots, and by application, encompassing Material Handling, Welding, Painting, and Assembly amongst others. Additionally, it explores various end-use industries, such as Automotive, Electrical and Electronics, Metals andโฆ

XX% Growth Projected for Mesotherapy Market, Reveals Dataintelo's Detailed Study โฆ
In an insightful investigation of the Mesotherapy Market, Dataintelo unveils a comprehensive analysis of the key growth markers, restraints, and business prospects that will shape the industry dynamics in the coming years. The report is segmented by Product Type (Plant Extracts, Hormones, Enzymes, Vitamins, Others), by Application (Non-Surgical Liposuction, Body Contouring, Hair Restoration, Others), by End-user (Hospitals, Speciality Clinics, Aesthetic Centers), and by Technique (Nappage, Point by Point, Mesoperfusion, Mesolift,โฆ
More Releases for Trastuzumab
Rising Breast And Gastric Cancer Prevalence Drives Trastuzumab Biosimilars Marke โฆ
"The Trastuzumab Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Trastuzumab Biosimilars Market Size and Projected Growth Rate?
The trastuzumab biosimilars market has seen rapid growth in recent years. It will grow from $4.27 billion in 2024 to $5.43 billion in 2025,โฆ
Leading Growth Driver in the Trastuzumab Biosimilars Market in 2025: Rising Brea โฆ
What Are the Market Size and Growth Forecast for the Trastuzumab Biosimilars Market?
The market for trastuzumab biosimilars has witnessed significant expansion in the past few years. The market is projected to increase from $4.27 billion in 2024 to $5.43 billion in 2025, with a compound annual growth rate (CAGR) of 27.1%. The historical growth patterns can be attributed to the expansion and globalization of the market, expiry of patents andโฆ
Leading Growth Driver in the Trastuzumab Biosimilars Market in 2025: Rising Brea โฆ
What Are the Market Size and Growth Forecast for the Trastuzumab Biosimilars Market?
The market for trastuzumab biosimilars has witnessed significant expansion in the past few years. The market is projected to increase from $4.27 billion in 2024 to $5.43 billion in 2025, with a compound annual growth rate (CAGR) of 27.1%. The historical growth patterns can be attributed to the expansion and globalization of the market, expiry of patents andโฆ
Herceptin (Trastuzumab) Market Overview,Recent Devolopment And Forecast During ( โฆ
This report presents an overview of global market for Herceptin (Trastuzumab), capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 - 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Herceptin (Trastuzumab), also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Herceptin (Trastuzumab), and key regions/countries ofโฆ
Trastuzumab Biosimilar Market Opportunities and Growth Challenges Report 2022-20 โฆ
Global Trastuzumab Biosimilar Market 2022-2028 - Global Industry Size, Supply Analysis, Price Analysis, Consumption and Production, Supplier and Cost Structure Analysis
Trastuzumab Biosimilar Market Overview
The recent market intelligence study by the research analysts at Market Business Insights (MBI) takes a deep dive into inner operations of the global Trastuzumab Biosimilar Market. It thoroughly examines the market landscape to give the readers an accurate insight into the current, as well as theโฆ
Trastuzumab Biosimilar Market 2022 | Detailed Report
According to Market Study Report, Trastuzumab Biosimilar Market provides a comprehensive analysis of the Trastuzumab Biosimilar Market segments, including their dynamics, size, growth, regulatory requirements, competitive landscape, and emerging opportunities of global industry. An exclusive data offered in this report is collected by research and industry experts team.
Download FREE Sample Report @ https://www.reportsnreports.com/contacts/requestsample.aspx?name=5511273
The report provides a comprehensive analysis of company profiles listed below:
- Amgen Inc.
- Pfizer Inc
- Samsung Bioepis
-โฆ